Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Biochemistry and Molecular Biology,
College of Basic Medical Science,
Department of Biochemistry and Molecular Biology, College of Basic Medical Science
Gang Huang has not added Biography.
If you are Gang Huang and would like to personalize this page please email our Author Liaison for assistance.
Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
Molecular cancer Aug, 2015 | Pubmed ID: 26302777
Activation of LXR attenuates collagen-induced arthritis via suppressing BLyS production.
Clinical immunology (Orlando, Fla.) Dec, 2015 | Pubmed ID: 26431776
Chlorogenic Acid Inhibits BAFF Expression in Collagen-Induced Arthritis and Human Synoviocyte MH7A Cells by Modulating the Activation of the NF-B Signaling Pathway.
Journal of immunology research , 2019 | Pubmed ID: 31240234
Reactive oxygen species-responsive dexamethasone-loaded nanoparticles for targeted treatment of rheumatoid arthritis via suppressing the iRhom2/TNF-α/BAFF signaling pathway.
Biomaterials 02, 2020 | Pubmed ID: 31918224
LncRNA-H19 silencing suppresses synoviocytes proliferation and attenuates collagen-induced arthritis progression by modulating miR-124a.
Rheumatology (Oxford, England) 01, 2021 | Pubmed ID: 32810279
Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.
Technology in cancer research & treatment Jan-Dec, 2020 | Pubmed ID: 33073697
Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Frontiers in immunology , 2020 | Pubmed ID: 33362779
LncRNA CRNDE Promotes ATG4B-Mediated Autophagy and Alleviates the Sensitivity of Sorafenib in Hepatocellular Carcinoma Cells.
Frontiers in cell and developmental biology , 2021 | Pubmed ID: 34409031
The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets.
MedComm Sep, 2021 | Pubmed ID: 34766153
Army Medical University
Hang You1,2,
Xin Mao2,
Chenyang Wang2,
Gang Huang3,
Marcus Groettrup4,5,
Jun Li2
1School of Medicine, Chongqing University,
2Department of Urological Oncology Surgery, Chongqing University Cancer Hospital,
3Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Army Medical University,
4Division of Immunology, Department of Biology, University of Konstanz,
5Biotechnology Institute Thurgau, University of Konstanz
Xin Mao*,1,
Peng Xian*,1,
Jun Li1
1Department of Urological Oncology Surgery, Chongqing University Cancer Hospital,
2School of Medicine, Chongqing University,
3Department of Biochemistry and Molecular Biology, College of Basic Medical Science, Army Medical University
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.